Literature DB >> 8212527

Changes in serum C-reactive protein levels in dogs with various disorders and surgical traumas.

S Yamamoto1, T Shida, S Miyaji, H Santsuka, H Fujise, K Mukawa, E Furukawa, T Nagae, M Naiki.   

Abstract

The serum levels of C-reactive protein (CRP) produced as an inflammatory response in dogs with various disorders and surgical traumas were measured by enzyme-linked immunoabsorbent assay and slide reversed passive latex agglutination test (RPLA). The CRP levels were greatly increased 1-2 days after surgery in most of the dogs (n = 29) subjected to surgery. These levels had markedly decreased by the time the sutures were removed. In dogs with various disorders (n = 58), the serum CRP levels at first diagnosis were high in infectious diseases. In dogs from which paired serum samples were examined, the serum CRP usually showed a decrease with improvement in the condition (n = 11) or a terminal increase (n = 4) but, conversely, some showed an increase with improvement in the condition (n = 3).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8212527     DOI: 10.1007/bf01839236

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  18 in total

1.  Quantitation of "acute-phase proteins" postoperatively. Value in detection and monitoring of complications.

Authors:  C L Fischer; C Gill; M G Forrester; R Nakamura
Journal:  Am J Clin Pathol       Date:  1976-11       Impact factor: 2.493

2.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Acute phase response in the dog following surgical trauma.

Authors:  J G Conner; P D Eckersall; J Ferguson; T A Douglas
Journal:  Res Vet Sci       Date:  1988-07       Impact factor: 2.534

4.  Serum levels of interleukin-6 and acute phase responses.

Authors:  M W Nijsten; E R de Groot; H J ten Duis; H J Klasen; C E Hack; L A Aarden
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

Review 5.  The phenomenon of the acute phase response.

Authors:  I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  Radioimmunoassay of human C-reactive protein and levels in normal sera.

Authors:  D R Claus; A P Osmand; H Gewurz
Journal:  J Lab Clin Med       Date:  1976-01

7.  Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.

Authors:  R K Mallya; F C de Beer; H Berry; E D Hamilton; B E Mace; M B Pepys
Journal:  J Rheumatol       Date:  1982 Mar-Apr       Impact factor: 4.666

8.  Isolation of canine C-reactive protein and characterization of its properties.

Authors:  S Yamamoto; K Tagata; H Nagahata; Y Ishikawa; M Morimatsu; M Naiki
Journal:  Vet Immunol Immunopathol       Date:  1992-01-31       Impact factor: 2.046

9.  Comparative study of serum amyloid A protein and C-reactive protein in disease.

Authors:  C P Maury
Journal:  Clin Sci (Lond)       Date:  1985-02       Impact factor: 6.124

10.  An immunoturbidimetric assay for canine C-reactive protein.

Authors:  P D Eckersall; J G Conner; J Harvie
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

View more
  21 in total

1.  Effects of hemolysis, lipemia, hyperbilirrubinemia, and anticoagulants in canine C-reactive protein, serum amyloid A, and ceruloplasmin assays.

Authors:  Silvi Martínez-Subiela; Jose J Cerón
Journal:  Can Vet J       Date:  2005-07       Impact factor: 1.008

2.  Effect of Mannheimia (Pasteurella) haemolytica infection on acute-phase proteins and some mineral levels in colostrum-breast milk-fed or colostrum-breast milk-deprived sheep.

Authors:  P A Ulutas; A Ozpinar
Journal:  Vet Res Commun       Date:  2006-07       Impact factor: 2.459

Review 3.  Acute phase response in animals: a review.

Authors:  Carolyn Cray; Julia Zaias; Norman H Altman
Journal:  Comp Med       Date:  2009-12       Impact factor: 0.982

4.  Serum and synovial fluid C-reactive protein level variations in dogs with degenerative joint disease and their relationships with physiological parameters.

Authors:  S Boal; L Miguel Carreira
Journal:  Vet Res Commun       Date:  2015-07-16       Impact factor: 2.459

5.  Physiological levels of C-reactive protein in normal canine sera.

Authors:  K Otabe; T Sugimoto; T Jinbo; M Honda; S Kitao; S Hayashi; M Shimizu; S Yamamoto
Journal:  Vet Res Commun       Date:  1998-02       Impact factor: 2.459

6.  Analytical and clinical validation of a time-resolved immunofluorometric assay (TR-IFMA) for canine C-reactive protein in serum.

Authors:  M D Parra; M Tuomola; J Cabezas-Herrera; J J Cerón
Journal:  Vet Res Commun       Date:  2006-02       Impact factor: 2.459

7.  Monitoring C-reactive protein in beagle dogs experimentally inoculated with Ehrlichia canis.

Authors:  T Shimada; Y Ishida; M Shimizu; M Nomura; K Kawato; K Iguchi; T Jinbo
Journal:  Vet Res Commun       Date:  2002-04       Impact factor: 2.459

8.  Relationship between assays of inflammation and coagulation: a novel interpretation of the canine activated clotting time.

Authors:  Teresa Cheng; Karol A Mathews; Anthony C G Abrams-Ogg; R Darren Wood
Journal:  Can J Vet Res       Date:  2009-04       Impact factor: 1.310

9.  Serum C-reactive protein and immune responses in dogs inoculated with Bordetella bronchiseptica (phase I cells).

Authors:  S Yamamoto; T Shida; M Honda; Y Ashida; Y Rikihisa; M Odakura; S Hayashi; M Nomura; Y Isayama
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

10.  C-reactive protein as an indicator of inflammatory responses to experimentally induced cystitis in dogs.

Authors:  Kyoung-won Seo; Jong-bok Lee; Jin-Ok Ahn; Hee-woo Lee; Cheol-yong Hwang; Hwa-young Youn; Chang-woo Lee
Journal:  J Vet Sci       Date:  2012-06       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.